| NCT Number | NCT07096206 |
| Lead Sponsor | Pierre Fabre Medicament |
| Conditions | X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) |
| Enrollment | 27 participants |
| Start Date | 2023-07-19 |
| Primary Completion | 2026-11-19 (estimated) |
| Study Completion | 2026-11-19 (estimated) |
| Updated on ClinicalTrials.gov | 2025-07-31 |